Enterprise Europe Network

A Korean SME is looking for a distributor for nasal inflammatory treatment device with multi-wave laser

Country of origin:
Country: 
SOUTH KOREA
Opportunity:
External Id: 
BOKR20191217001
Published
17/12/2019
Last update
20/01/2020
Expiration date
20/01/2021

Keywords

Partner keyword: 
Optical Materials
Medical instruments
EXPRESS YOUR INTEREST

Summary

Summary: 
This company from Korea which mainly manufactures optical components has developed a new product/device for nasal inflammatory treatment. The device uses a multi-wave laser and is based on low-level laser therapy to cure the inflammation inside the nose. This company wants to have a partner in Europe who has specialized in the distribution of healthcare products especially in the field of otolaryngology.

Description

Description: 

This Korean company is specialized in the manufacturing of optical components for over 16 years. This company has been developing new technologies related between optics and healthcare based on its own specialty.
The main technology of this product is a multi-wave laser which is based on low-level laser therapy (LLLT). Low light level laser therapy supports the body to increase the number of cells by irradiating the light to facilitate the blood volume, oxygen supply and nutrient supply of cells. This helps the blood flow to be normalized with the reduction of chronic inflammation. Comparing with medication which is the most common treatment for nasal inflammation patients don't need to take the medicine continuously. Furthermore, this product supplements the limitation of current laser treatment which is that the inflammation could relapse over time as single-wave lasers are limited to irradiate inside the nostril. On the other hand, multi-wave lasers can cure the inflammation in the nostril as well as the nasal cavity. The wavelength of laser light is 670 mm at one point and 830 mm of multi-waves. This wavelength of laser light stimulates cells inside the nose to relieve the inflammation especially because of the hypersensitive response. The effects come out when patients use this product for about 1 month.
The product was developed in 2010, and is currently being sold in Korea and Thailand as well. More recently, it is under test in Vietnam for market entry as well. In line with the company's goal to expand in the global market, they are also seeking for a partner in Europe who is closely linked to otolaryngology or a drugstore to enter into a distribution services agreement.

Advantages & innovations

Cooperation plus value: 
Patients that use this device will have no need to take medicines for an extended period of time: - Prevent drug-resistance and reduction of effectiveness of drugs - It overcomes the limitation of current laser procedure - Easy to suit the wavelength to the treatment required - Prevent the re-occurrence of inflammation By using the specific wavelength from the laser light, this product can be used to relieve the nasal inflammation.

Stage of development

Cooperation stage dev stage: 
Already on the market

Partner sought

Cooperation area: 
Type: This company seeks any size of companies with the ability to distribute this product into Europe. Activity: Company which has close links with otolaryngology or drugstores are preferred. Role: This company wants to have a partner to have a chance of exploring its own products into the European market under the distribution services agreement.

Type and size

Cooperation task: 
SME 11-50,SME <10,>500 MNE,251-500,SME 51-250,>500